Skip to main content
Renata Jurkowska

Dr Renata Jurkowska

Reader

School of Biosciences

Users
Available for postgraduate supervision

Overview

How can the same genetic sequence give rise to more than 200 cell types found in the human body, each with unique morphology and function?

I have always been fascinated by the processes of cellular differentiation, which illustrates how the genetic alphabet can elegantly be interpreted by an interplay of epigenetic processes to drive progenitor cells towards their specialized fates. This amazement has fueled the development of my research interests around epigenetics and stem cell differentiation.

My long-term research interests are to understand:

1) How different populations of human lung cells cooperate to form a functional organ

2) How epigenetic regulation drives cellular identity in the healthy lung

3) How dysregulation of epigenetic processes due to environmental insults, like cigarette smoke or air pollution contributes to development of lung diseases

Publication

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2008

2007

2006

Adrannau llyfrau

Erthyglau

Llyfrau

Research

The human lung is built by more than 50 cell types, which cooperate to create a beautiful organ essential for us to breathe. Critically, lack of regenerative capacity is a key feature of many lung diseases and ageing. Hence, understanding molecular processes required for lung regeneration is vitally important for biological research. 

Our group investigates how epigenetic regulation drives cellular identity in the human lung with the aim of discovering novel therapeutic interventions for lung regeneration.

To develop new treatments, we need to understand how healthy individuals develop lung diseases and identify suitable targets for drug development. Epigenetic modifications are chemical groups on our genetic information that determine which genes are active and which are shut off. They get dysregulated by environmental exposures causing disease. Excitingly, they can also be manipulated with the potential to cure disease. Thus, epigenetic signalling provides an exciting and largely unexplored level of regulation for the identification of disease-driving events, novel disease regulators, and biomarkers.

We employ genome-wide epigenomic assays and single-cell -omics approaches in combination with CRISPR-based epigenetic editing tools and 3D organoid models, to advance the biological understanding of lung cell differentiation and identify epigenetic biomarkers and novel therapeutic strategies for patients with chronic respiratory diseases.

 

Teaching

Module contributor: BI2331 Physiology

Module contributor: BI2332 Concepts of Disease

Module contributor: BI3254 Genes to Genomes

Module contrributor: BI3252 Omics Revolution

Biography

Since September 2019 I have been a Senior Lecturer in the Biomedicine Division within the School of Biosciences at Cardiff University, where I have the pleasure to work in a highly collaborative and inspiring research environment. I have recently secured the UKRI Future Leaders Fellowship, which I started in June 2024. 

After completing my BSc and MSc studies in Biotechnology at Warsaw University in Poland, I joined the group of Prof. Albert Jeltsch (Jacobs University Bremen, Germany) for PhD studies in Biochemistry, which I concluded with special distinction. I investigated the enzymatic properties and regulation of human DNA methyltransferases, key enzymes involved in cellular identity and function. My PhD triggered a long-life fascination with epigenetics and crystallised my research interests around stem cell differentiation and tissue regeneration. During my postdoctoral time (initially at Jacobs University Bremen, Germany and then at the University of Stuttgart, Germany), I investigated the mechanisms of different classes of epigenetic enzymes to understand their function and contribution to human diseases.

I like exploring emerging fields and engaging in interdisciplinary projects. Therefore, after my postdoc, I changed my research field from biochemistry to lung diseases and the research sector from academia to a start-up company. From the end of 2015 until July 2019, I was a group leader of the Epigenetics and COPD research team at BioMed X Innovation Center in Heidelberg (Germany), an institution promoting a novel collaboration model at the interface between academia and industry. There, I designed and successfully delivered an innovative research project carried out in collaboration with the pharma industry, which explored epigenetic regulation of chronic obstructive pulmonary disease to provide novel therapeutic avenues for this uncurable lung disease. The success of the project and its impact were demonstrated by the acquisition of all results by the pharma partner for internal continuation.

Honours and awards

  • UKRI Future Leaders Fellowship (2024)
  • Fellow of the Higher Education Academy (FHEA) (2023)
  • Academy of Medical Sciences Springboard Award (2022)
  • Geoffrey Laurent Award for the Best Oral Presentation at the Lung Science Conference, Portugal (2024 and 2020)
  • Cardiff Futures Program Awardee (2021)
  • Welsh Crucible Program Awardee (2021)
  • Postdoctoral fellowship and research grant awarded by the Carl Zeiss Foundation (2015)
  • EMBO short-term fellowship award (2014)
  • Best poster award at the 6th NEB meeting and workshop, Bremen, Germany (2010)
  • Scholarship for distinguished scientific achievements from Polish Ministry of Education (2004-2003 and 2003-2002)
  • Scholarship granted for distinguished achievements, Warsaw University, Poland (2004-2000)

Professional memberships

  • Member of the British Association for Lung Research (BALR) (from 2019) and BALR executive committee member (from 2023)
  • Member of the Revision Committee of the International Society for Molecular and Clinical Epigenetics (isMOCLEP) (from 2022) 
  • Member of the Welsh Thoracic Society (from 2021) and WTS executive committee member (2022)
  • Member of the Biochemical Society (from 2019)
  • Member of the European Respiratory Society (from 2016)

Academic positions

  • June 2024 - present: UKRI Future Leaders Fellow
  • 2019 - present: Senior Lecturer, Cardiff University
  • 2015 - 2019: Project and Group Leader at BioMed X Innovation Center (Heidelberg, Germany)
  • 2012 - 2019: Postdoctoral Researcher, Stuttgart University (Germany)
  • 2009 - 2011: Postdoctoral Researcher, Jakobs University Bremen (Germany)

Speaking engagements

Selected examples of recent speaker invitations:

  • European Respiratory Society Congress, Vienna, Austria (2024)
  • American Thoracic Society, San Diego, USA (2024)
  • Seminar talk at the MTWC for Fibrosing Lung Disease Seminar Series, Imperial College London, UK (2024)
  • British Association for Lung Research meeting, Dundee, UK (2024)
  • Seminar talk at Wellcome-Wolfson Institute for Experimental Medicine, Belfast, Northern Irland (2024)
  • World Laureate Forum, Shanghai, China (nomination from the Academy of Medical Sciences) (2024)
  • Seminar talk at the Shanghai Institute for Nutrition and Health, Chinese Academy of Sciences, China (2024)
  • Epigenetics Society International Meeting, Rome, UK (2023)
  • British Thoracic Society Meeting, London, UK (2023)
  • Welsh Thoracic Society meeting, Cardiff, UK (2023)
  • Speaker seminar presentation for the COPDiNET network (online) (2023)

 

Committees and reviewing

  • Member of the BBSRC Pool of Experts, BBSRC Doctoral Landscape Award panel and BBSRC Responsive Mode Committee C panel (from January 2024)
  • Member of the UKRI Talent Peer Review College and reviewer for the UKRI Future Leaders Fellowship Scheme (from 2023)
  • Grant reviewer for the UKRI, Welcome Trust, Polish Science Foundation and French Science Foundation
  • Member of the Editorial Board of Clinical Epigenetics (from 2022), Epigenetic Communications (from 2022) and Epigenomes (from 2018)
  • Journal reviewer of diverse journals, including Nucleic Acid Research, European Respiratory Journal, Nature Reviews Molecular Cell Biology, Science Advances, Clinical Epigenetics and Chromatin and Epigenetics.

Supervisions

I am interested in supervising PhD students in the areas of:

  • epigenetics
  • stem cell differentiation
  • lung biology
  • chronic lung diseases
  • development of new epigenomic profiling technologies

Current Lung Epigenetics Group members:

Dr Stephanie Pohl (PDRA)

Darius Pease (PhD student)

Petar Popov (PhD student / Teaching Associate)

Pheobe Ross (PhD student)

Megan Nicholson (MPhil student)

Laura Sear (Integrated master student)

 

Past Lung Epigenetics Group members:

Dr Xinsheng Nan (PDRA)

Renjiao Li (visiting PhD student from China)

Stephanie Pohl (PhD student)

Isaac Al-Moosawi (MRes student)

Diana Stoian (MRes student)

Alex Titimeaua (MRes student)

Alice Pike (Integrated master student)

Jacob Hill (Integrated master student)

Amelia Nathan (Integrated master student)

Deborah Ackesson (Integrated master student)

Simran Tac (MSc in Tissue Engineering and Regenerative Medicine student)

Arthur Pasanen-Zentz (MSc in Tissue Engineering and Regenerative Medicine student)

 

Contact Details

Email JurkowskaR@cardiff.ac.uk
Telephone +44 29208 79067
Campuses Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX

Research themes

Specialisms

  • Epigenetics
  • Respiratory diseases
  • Ageing